Star Health Q2 FY27 Earnings Call Transcript Released
Star Health's Q2 & H1 FY27 Earnings Call transcript is available. The company reported a 19% YoY increase in GWP for Q2 FY27 to ₹5,275 crore and H1 FY27 to ₹9,562 crore. Underwriting results swung to a profit of ₹99 crore in Q2 and ₹210 crore in H1 FY27. PAT for Q2 FY27 surged over threefold to ₹265 crore.
The release of an earnings call transcript provides detailed insights into the company's financial performance and future outlook, which is important for investors and analysts. However, the core financial results were likely announced earlier, making this a supplementary disclosure.
The company reported strong financial performance with significant growth in GWP, a turnaround in underwriting results, and a substantial increase in PAT. Management expressed confidence in the company's strategic direction and resilience.
Star Health and Allied Insurance Company Limited has released the transcript of its Q2 and H1 FY2027 Earnings Call, which took place on October 28, 2026. The call featured management including Mr. Anand Roy (MD & CEO), Mr. Amitabh Jain (ED & COO), Mr. Himanshu Walia (ED & CMO), Mr. Nilesh Kambli (CFO), Mr. Aneesh Srivastava (CIO), and Mr. Sombit Bhattacharyya (Head Investor Relations).
During the call, the management highlighted a significant turnaround in underwriting performance, marking the 5th consecutive quarter of improvement in loss ratios. Gross written premium (GWP) increased by 19% year-on-year for Q2 FY27 to ₹5,275 crore and by 19% for H1 FY27 to ₹9,562 crore. Fresh retail health GWP saw robust growth of 35% year-on-year for the quarter and 36% for the half-year. The new-to-insurance mix rose to 93% in Q2 FY27.
Underwriting results for Q2 FY27 stood at ₹99 crore, a positive swing from a loss of ₹40 crore in the previous year's quarter. For H1 FY27, underwriting results were ₹210 crore, compared to a loss of ₹24 crore in H1 FY26. The Profit After Tax (PAT) for the quarter increased over threefold to ₹265 crore, and for the half-year, it rose by 57% year-on-year to ₹815 crore.
The company's strategy recalibration has led to a structural turnaround in operating performance. Digital and AI initiatives are central to their growth strategy, with AI bots processing significant call volumes at a fraction of the cost of human deployment. The company also discussed recent regulatory developments, including the proposed Public Insurance Registry and the consultation paper on recalibrating insurance distribution economics, expressing confidence in their business model's resilience and alignment with proposed reforms.
Management reiterated their focus on preferred segments, disciplined risk selection, and leveraging proprietary channels like agency and digital D2C, which contribute over 90% of their retail business. They aim to maintain a consistent fresh business growth of over 20%.
What to do with a filing like this
Star Health and Allied Insurance Company Limited filed this with the NSE as a statutory disclosure, categorised under concall transcript released. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Star Health and Allied Insurance Company Limited. Read the original for the full detail.